Breast Cancer in the Post-Genomic Era
Breast Cancer is the most common tumor in women and it is the second leading cause of cancer deaths worldwide. Due to breakthroughs in gene profiling, the knowledge of the pathophysiology of the mammary gland had greatly increased over the last decade. In Breast Cancer in the Post Genomic Era, Anton...
Corporate Author: | |
---|---|
Other Authors: | , |
Format: | Electronic |
Language: | English |
Published: |
Totowa, NJ :
Humana Press,
2009.
|
Series: | Current Clinical Oncology
|
Subjects: | |
Online Access: | https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-60327-945-1 |
Table of Contents:
- The genomic basis of breast development and differentiation
- Mammary Glands, Stem Cells and Breast Cancer
- The genetics of breast cancer: application in clinical practice
- Alterations in cell cycle regulatory genes in breast cancer
- Neuregulins in the nucleus
- Role of the EGF-CFC family in mammary gland development and neoplasia
- Modeling human breast cancer: the use of transgenic mice
- Gene expression profiling in breast cancer: clinical applications
- TGF-B signaling: a novel target for treatment of breast cancer?- DNA methylation in breast cancer
- Signal transduction inhibitors in the treatment of breast cancer
- Integration of target based agents in current protocols of breast cancer therapy.